Position in ACET
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,693
+$1,639 QoQ
Shares Held
196
+2350.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 56 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ACET ranks #357 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ACET
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,693 | 196 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $54 | 8 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $100 | 12 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $624 | 771 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $470 | 771 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $883 | 1,170 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $144,765 | 150,485 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $115,708 | 80,353 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $932 | 771 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $139,219 | 59,243 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $37,478 | 19,830 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $38,326 | 27,976 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $62,717 | 25,810 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $134,369 | 23,328 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $158,382 | 17,812 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $260,936 | 18,350 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $247,366 | 16,943 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $334,816 | 16,766 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $248,391 | 14,202 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $92,134 | 11,752 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $97,918 | 9,516 | Shares | Defined | 2021-08-12 | |
| 2020-12-31 | $5,353 | 381 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $35 | 3 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 TORC | — | 18 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 TORC | — | 62,852 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||